Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
QF-PCR and maternal cell contamination by Dr Kathy Mann, the pioneer in prenatal QF-PCR analysis.
The ability to identify maternal cell contamination (MCC) in uncultured AF and CV samples minimises the risk of misdiagnosis due to the analysis of maternal cells. Authored by Dr. Kathy Manns, the pioneer in prenatal QF-PCR analysis, this paper provides information for laboratory professionals on how to identify the presence and level of MCC in a prenatal sample using a QF-PCR based approach.
QF-PCR and maternal cell contamination by Dr Kathy Mann, the pioneer in prenatal QF-PCR analysis.
The ability to identify maternal cell contamination (MCC) in uncultured AF and CV samples minimises the risk of misdiagnosis due to the analysis of maternal cells. Authored by Dr. Kathy Manns, the pioneer in prenatal QF-PCR analysis, this paper provides information for laboratory professionals on how to identify the presence and level of MCC in a prenatal sample using a QF-PCR based approach.
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
Read More
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More